Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.94 USD | +11.65% | +8.59% | +5.13% |
Apr. 29 | UBS Adjusts Monte Rosa Therapeutics Price Target to $20 From $22, Maintains Buy Rating | MT |
Mar. 14 | Monte Rosa Therapeutics Q4 Net Loss Narrows; Shares Decline | MT |
Financials (USD)
Sales 2024 * | 6.18M | Sales 2025 * | 5.93M | Capitalization | 299M |
---|---|---|---|---|---|
Net income 2024 * | -143M | Net income 2025 * | -171M | EV / Sales 2024 * | 28.7 x |
Net cash position 2024 * | 122M | Net cash position 2025 * | 171M | EV / Sales 2025 * | 21.5 x |
P/E ratio 2024 * |
-2.57
x | P/E ratio 2025 * |
-2.56
x | Employees | 133 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.11% |
Latest transcript on Monte Rosa Therapeutics, Inc.
1 day | +11.65% | ||
1 week | +8.59% | ||
Current month | +11.65% | ||
1 month | -16.81% | ||
3 months | +20.00% | ||
6 months | +73.68% | ||
Current year | +5.13% |
Managers | Title | Age | Since |
---|---|---|---|
Markus Warmuth
CEO | Chief Executive Officer | 53 | 19-12-31 |
Chief Operating Officer | - | 21-02-28 | |
Filip Janku
CTO | Chief Tech/Sci/R&D Officer | 50 | 21-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew Schiff
BRD | Director/Board Member | 58 | 20-08-31 |
Christine Siu
BRD | Director/Board Member | 47 | 20-11-30 |
Chandra Paul Leo
BRD | Director/Board Member | 55 | 20-08-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.00% | 9 M€ | +5.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 5.94 | +11.65% | 156,388 |
24-04-30 | 5.32 | -5.17% | 92,522 |
24-04-29 | 5.61 | +5.25% | 89,395 |
24-04-26 | 5.33 | -2.20% | 87,737 |
24-04-25 | 5.45 | -0.37% | 134,428 |
Delayed Quote Nasdaq, May 01, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.13% | 268M | |
+0.67% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+6.55% | 24.63B | |
-21.66% | 18.2B | |
+29.96% | 12.01B | |
-1.57% | 11.76B | |
+16.03% | 10.4B | |
-4.80% | 9.94B |
- Stock Market
- Equities
- GLUE Stock